AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
16,672,269
Share change
-194,876
Total reported value
$39,345,972
Price per share
$2.36
Number of holders
32
Value change
-$524,138
Number of buys
7
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q2 2019

As of 30 Jun 2019, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,672,269 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., OxFORD Asset Management LLP, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.